PLCEI Mutations and New Genes in FSGS
| Main study | Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis: Phase II Clinical Trial |
|---|---|
| Contact name | Friedhelm Hilderbrant |
| Contact phone | 734-764-7145 |
| Contact email | fhilde@med.umich.edu |
| Main study | Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis: Phase II Clinical Trial |
|---|---|
| Contact name | Friedhelm Hilderbrant |
| Contact phone | 734-764-7145 |
| Contact email | fhilde@med.umich.edu |